lusa, sara
 Distribuzione geografica
Continente #
EU - Europa 47
AS - Asia 24
NA - Nord America 24
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 100
Nazione #
IT - Italia 23
US - Stati Uniti d'America 23
VN - Vietnam 10
NL - Olanda 7
IE - Irlanda 6
UA - Ucraina 6
KR - Corea 4
AU - Australia 3
TW - Taiwan 3
AT - Austria 2
CN - Cina 2
CZ - Repubblica Ceca 2
IN - India 2
IR - Iran 2
CA - Canada 1
CI - Costa d'Avorio 1
CL - Cile 1
DE - Germania 1
JP - Giappone 1
Totale 100
Città #
Dong Ket 10
Dublin 5
Amsterdam 4
Ashburn 4
Naples 4
Napoli 3
San Jose 3
Alpignano 2
Ercolano 2
Eunpyeong-gu 2
Florence 2
Melbourne 2
Mugnano di Napoli 2
Vienna 2
Alexandria 1
Basking Ridge 1
Berlin 1
Brisbane 1
Buffalo 1
Campobasso 1
Cervere 1
Chang-hua 1
Council Bluffs 1
Genoa 1
Hsinchu 1
Kanpur 1
Lauro 1
Milan 1
Mountain View 1
New York 1
Noida 1
Nunoa 1
Ottawa 1
Taipei 1
Tokyo 1
Vicenza 1
Washington 1
Wilmington 1
Yuseong-gu 1
Totale 72
Nome #
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer, file e268a732-61d2-4c8f-e053-1705fe0a812c 47
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR, file e268a732-2644-4c8f-e053-1705fe0a812c 21
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells, file e268a732-2830-4c8f-e053-1705fe0a812c 15
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors, file e268a732-61d0-4c8f-e053-1705fe0a812c 10
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells, file e268a732-66ca-4c8f-e053-1705fe0a812c 7
Totale 100
Categoria #
all - tutte 472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 3 0 0 0 1 1 5
2021/202216 6 0 0 1 0 2 1 0 2 1 2 1
2022/202329 1 0 0 0 1 4 2 2 0 6 12 1
2023/202445 2 3 12 6 4 2 7 4 3 2 0 0
Totale 100